Unusually Rapid Development of Pulmonary Hypertension and Right Ventricular Failure after COVID-19 Pneumonia

van Dongen, Christel MP and Janssen, Marlou THF and van der Horst, Robrecht PJ and van Kraaij, Dave JW and Peeters, Ralph HRM (2020) Unusually Rapid Development of Pulmonary Hypertension and Right Ventricular Failure after COVID-19 Pneumonia. European Journal of Case Reports in Internal Medicine, 7 (7). pp. 1-3. ISSN ISSN: 2284-2594

[img]
Preview
Text
1784-Article Text-14421-1-10-20200617.pdf - Published Version

Download (505kB) | Preview
Official URL: https://www.ejcrim.com/index.php/EJCRIM/issue/view...

Abstract

COVID-19 is a novel viral disease caused by SARS-CoV-2. The mid- and long-term outcomes have not yet been determined. COVID-19 infection is increasingly being associated with systemic and multi-organ involvement, encompassing cytokine release syndrome and thromboembolic, vascular and cardiac events. The patient described experienced unusually rapid development of pulmonary hypertension (PH) and right ventricular failure after recent severe COVID-19 pneumonia with cytokine release syndrome, which initially was successfully treated with methylprednisolone and tocilizumab. The development of pulmonary hypertension and right ventricular failure – in the absence of emboli on multiple CT angiograms – was most likely caused by progressive pulmonary parenchymal abnormalities combined with microvascular damage of the pulmonary arteries (group III and IV pulmonary hypertension, respectively). To the best of our knowledge, these complications have not previously been described and therefore awareness of PH as a complication of COVID-19 is warranted.

Item Type: Article
Uncontrolled Keywords: COVID-19, coagulopathy, microvascular damage, pulmonary hypertension, right ventricular failure
Subjects: 600 Tecnologia - Scienze applicate
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici)
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Marina Spanti
Date Deposited: 14 Dec 2021 14:25
Last Modified: 14 Dec 2021 14:25
URI: http://eprints.bice.rm.cnr.it/id/eprint/20918

Actions (login required)

View Item View Item